<code id='AF26A12E2A'></code><style id='AF26A12E2A'></style>
    • <acronym id='AF26A12E2A'></acronym>
      <center id='AF26A12E2A'><center id='AF26A12E2A'><tfoot id='AF26A12E2A'></tfoot></center><abbr id='AF26A12E2A'><dir id='AF26A12E2A'><tfoot id='AF26A12E2A'></tfoot><noframes id='AF26A12E2A'>

    • <optgroup id='AF26A12E2A'><strike id='AF26A12E2A'><sup id='AF26A12E2A'></sup></strike><code id='AF26A12E2A'></code></optgroup>
        1. <b id='AF26A12E2A'><label id='AF26A12E2A'><select id='AF26A12E2A'><dt id='AF26A12E2A'><span id='AF26A12E2A'></span></dt></select></label></b><u id='AF26A12E2A'></u>
          <i id='AF26A12E2A'><strike id='AF26A12E2A'><tt id='AF26A12E2A'><pre id='AF26A12E2A'></pre></tt></strike></i>

          Home / entertainment / explore

          explore


          explore

          author:Wikipedia    Page View:2875
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In